Echo IQ Limited (ASX: EIQ)

Echo IQ Limited (ASX: EIQ) is an Australian-based medical technology company focused on artificial intelligence solutions for cardiac diagnostics.

The company’s core product is EchoSolv, an AI-driven decision support tool designed to assist clinicians in detecting structural heart disease using echocardiography. The technology aims to reduce misdiagnosis and improve clinical workflow efficiency.

Echo IQ has achieved key regulatory milestones, including FDA clearance in the United States. The company is progressing commercialisation through strategic partnerships, including its collaboration with the Mayo Clinic.

Echo IQ is positioning itself within the growing digital health and AI diagnostics sector, targeting improved patient outcomes and more efficient healthcare delivery.